Year |
Citation |
Score |
2018 |
Li N, Lopez MA, Linares M, Kumar S, Oliva S, Martinez-Lopez J, Xu L, Xu Y, Perini T, Senapedis W, Baloglu E, Shammas MA, Hunter ZR, Anderson KC, Treon SP, et al. Dual PAK4-NAMPT inhibition impacts growth and survival, and increases sensitivity to DNA-damaging agents in Waldenstrom Macroglobulinemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30206161 DOI: 10.1158/1078-0432.CCR-18-1776 |
0.324 |
|
2018 |
Kashyap T, Argueta C, Unger T, Klebanov B, Debler S, Senapedis W, Crochiere ML, Lee MS, Kauffman M, Shacham S, Landesman Y. Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents. Oncotarget. 9: 30773-30786. PMID 30112106 DOI: 10.18632/oncotarget.25637 |
0.404 |
|
2014 |
Gravina GL, Senapedis W, McCauley D, Baloglu E, Shacham S, Festuccia C. Nucleo-cytoplasmic transport as a therapeutic target of cancer. Journal of Hematology & Oncology. 7: 85. PMID 25476752 DOI: 10.1186/s13045-014-0085-1 |
0.321 |
|
2011 |
Senapedis WT, Kennedy CJ, Boyle PM, Silver PA. Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. Molecular Biology of the Cell. 22: 1791-805. PMID 21460183 DOI: 10.1091/Mbc.E10-10-0854 |
0.516 |
|
2010 |
Aldaye FA, Senapedis WT, Silver PA, Way JC. A structurally tunable DNA-based extracellular matrix. Journal of the American Chemical Society. 132: 14727-9. PMID 20925350 DOI: 10.1021/Ja105431H |
0.376 |
|
2010 |
Gómez-Baldó L, Schmidt S, Maxwell CA, Bonifaci N, Gabaldón T, Vidalain PO, Senapedis W, Kletke A, Rosing M, Barnekow A, Rottapel R, Capellá G, Vidal M, Astrinidis A, Piekorz RP, et al. TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle (Georgetown, Tex.). 9: 1143-55. PMID 20237422 DOI: 10.4161/Cc.9.6.11018 |
0.444 |
|
2006 |
Astrinidis A, Senapedis W, Henske EP. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner Human Molecular Genetics. 15: 287-297. PMID 16339216 DOI: 10.1093/Hmg/Ddi444 |
0.38 |
|
2003 |
Astrinidis A, Senapedis W, Coleman TR, Henske EP. Cell Cycle-regulated Phosphorylation of Hamartin, the Product of the Tuberous Sclerosis Complex 1 Gene, by Cyclin-dependent Kinase 1/Cyclin B Journal of Biological Chemistry. 278: 51372-51379. PMID 14551205 DOI: 10.1074/Jbc.M303956200 |
0.336 |
|
2002 |
Khare L, Astrinidis A, Senapedis W, Adams PD, Henske EP. Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells Journal of Medical Genetics. 39: 676-680. PMID 12205112 DOI: 10.1136/Jmg.39.9.676 |
0.383 |
|
Show low-probability matches. |